BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8466741)

  • 1. Beneficial effect of isradipine on the development of left ventricular hypertrophy in mild hypertension.
    Mehlsen J; Gleerup G; Haedersdal C; Winther K
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):95S-97S. PubMed ID: 8466741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy with isradipine antihypertensive therapy.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Soulas DK; Toutouzas PK
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):82S-85S. PubMed ID: 8466736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
    Gleerup G; Mehlsen J; Winther K
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):87-9. PubMed ID: 7723358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients.
    Manolis AJ; Kolovou G; Handanis S; Athanasopoulos G; Antonopoulos S; Cokkinos DV
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):86S-88S. PubMed ID: 8466737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enalapril and isradipine alone and in combination on blood pressure, renal function and echocardiographic parameters in mild hypertension.
    De Rosa ML; Maddaluno G; Lionetti F; Di Palma U; Albanese L; Cardace P; Baiano A; Vigorito C
    Int J Cardiol; 2000 Jun; 74(1):77-84. PubMed ID: 10854683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients.
    Carr AA; Prisant LM
    Am J Hypertens; 1990 Jan; 3(1):8-15. PubMed ID: 2137344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium channel blockade on skin blood flow in diabetic hypertension: a comparison of isradipine and atenolol.
    Rendell MS; Shehan MA; Kahler K; Bailey KL; Eckermann AJ
    Angiology; 1997 Mar; 48(3):203-13. PubMed ID: 9071195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
    Perry HM; Hall WD; Benz JR; Bartels DW; Kostis JB; Townsend RR; Due DL; Peng A; Sirgo M
    Am J Med; 1994 Jan; 96(1):77-86. PubMed ID: 8304366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
    Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effectiveness of isradipine SRO in the treatment of hypertensive patients with left ventricular hypertrophy.
    Modena MG; Masciocco G; Rossi R; Baraldi P; Mattioli G
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):153-60. PubMed ID: 8086326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of mibefradil and atenolol on regression of left ventricular hypertrophy in hypertensive patients.
    Höglund C; Cifkova R; Mimran A; Tenczer J; Watt A; Wilkins MR; Lindberg E
    Cardiology; 1998 May; 89(4):263-70. PubMed ID: 9643273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of left ventricular hypertrophy with isradipine induces diminution of cardiac arrhythmias.
    Saragoça MA; Cassiolatto JL; Vanetta AM; Canziani ME; Abreu P; Ventura RT; Ramos OL
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):89S-91S. PubMed ID: 8466738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
    Mörtsell D; Malmqvist K; Held C; Kahan T
    J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
    Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries.
    Thürmann PA; Stephens N; Heagerty AM; Kenedi P; Weidinger G; Rietbrock N
    Hypertension; 1996 Sep; 28(3):450-6. PubMed ID: 8794832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
    Salo TM; Kantola I; Voipio-Pulkki LM; Pelttari L; Viikari JS
    Eur J Clin Pharmacol; 1999 May; 55(3):191-8. PubMed ID: 10379634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.